Wells Fargo’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
NCNMGF
FCM
SAM
KCM
MBAM
Wells Fargo's XGN Position: Q2 2026 in Review
Wells Fargo held its Exagen (XGN) position steady in Q2 2026 at 2,387 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6051.
Wells Fargo first reported a position in XGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $177K in Q2 2020. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.
- Wells Fargo held 2,387 shares of Exagen worth $11.1K as of Q2 2026.
- Wells Fargo left its Exagen share count unchanged in Q2 2026.
- Exagen made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6051 holding.
- Wells Fargo first reported a position in Exagen in Q4 2019 and has held it in 27 quarters since.
- Wells Fargo's Exagen position peaked at $177K in Q2 2020.
- 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.